Shoulder Innovations

SIPre-clinical

Shoulder Innovations is a private orthopedic device company dedicated to solving the most significant problem in shoulder replacement: glenoid implant loosening. Its proprietary InSet® Glenoid technology offers a differentiated, bone-preserving fixation method with strong clinical data supporting longer implant survivorship. With a seasoned leadership team from major orthopedic players and a focus on economic efficiency for both hospitals and ASCs, the company is positioned to capture share in the growing shoulder arthroplasty market.

SI · Stock Price

USD 14.300.75 (-4.98%)

Historical price data

AI Company Overview

Technology Platform

The InSet® platform utilizes an 'inlay' glenoid fixation design, where the implant is set into a reamed bony pocket rather than sitting on top of the bone. This aims to provide superior initial stability, promote bone ingrowth, preserve bone stock, and improve long-term survivorship of shoulder arthroplasty implants.

Funding History

Total raised: $125M

IPO$75MUndisclosedJun 29, 2023

Series B$35MDeerfield ManagementJun 15, 2020

Series A$15MUndisclosedJan 15, 2018

Opportunities

Significant growth is driven by the expanding shoulder arthroplasty market, particularly the rapid migration of procedures to cost-sensitive Ambulatory Surgery Centers (ASCs) where the company's streamlined system is advantageous.

Building a robust library of long-term clinical data demonstrating reduced revision rates presents a powerful tool for converting surgeons from established competitors.

Risk Factors

Key risks include intense competition from large, well-capitalized orthopedic giants with entrenched market positions, the challenge of driving surgeon adoption of a novel surgical technique, and the need to continually generate long-term clinical data to validate claims of superior implant survivorship.

Competitive Landscape

Competes directly with major orthopedic companies like Stryker, Zimmer Biomet, Johnson & Johnson (DePuy), and Arthrex. Its primary differentiation is the InSet® glenoid's inlay fixation design, which directly targets the leading cause of implant failure (glenoid loosening), and its lateralized-lateralized reverse shoulder system designed for improved biomechanics.